11,017 Shares in Cigna Group $CI Acquired by Livforsakringsbolaget Skandia Omsesidigt

Livforsakringsbolaget Skandia Omsesidigt purchased a new stake in Cigna Group (NYSE:CI) in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 11,017 shares of the health services provider’s stock, valued at approximately $3,037,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Twin Lakes Capital Management LLC bought a new stake in Cigna Group during the second quarter worth $174,000. Rakuten Investment Management Inc. acquired a new stake in shares of Cigna Group in the 2nd quarter valued at approximately $12,046,000. Glenview Trust Co acquired a new position in Cigna Group during the 2nd quarter worth approximately $5,766,000. Empowered Funds LLC acquired a new stake in Cigna Group in the second quarter valued at approximately $27,212,000. Finally, United Capital Financial Advisors LLC bought a new position in shares of Cigna Group in the 2nd quarter valued at $3,460,000. Institutional investors own 86.99% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the stock. Morgan Stanley raised their price objective on shares of Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a report on Wednesday, May 20th. Jefferies Financial Group lowered Cigna Group from a “buy” rating to a “hold” rating and cut their price objective for the stock from $336.00 to $307.00 in a research note on Tuesday, August 4th. Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a research report on Monday, June 1st. Wells Fargo & Company boosted their price target on shares of Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Finally, Barclays lifted their target price on shares of Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. Fifteen equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $339.45.

Cigna Group Price Performance

Shares of CI opened at $278.89 on Friday. The business’s fifty day moving average is $283.52 and its 200 day moving average is $281.39. Cigna Group has a 12-month low of $239.51 and a 12-month high of $315.47. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. The stock has a market cap of $73.69 billion, a P/E ratio of 11.54, a P/E/G ratio of 0.96 and a beta of 0.29.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business had revenue of $70.04 billion during the quarter, compared to analyst estimates of $70.14 billion. During the same quarter in the previous year, the business posted $7.20 EPS. Cigna Group’s quarterly revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Sell-side analysts anticipate that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s payout ratio is 25.82%.

Insider Buying and Selling

In related news, insider Nicole S. Jones sold 2,677 shares of the company’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total transaction of $748,515.97. Following the completion of the sale, the insider owned 25,880 shares in the company, valued at approximately $7,236,306.80. This represents a 9.37% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the transaction, the chief accounting officer owned 2,368 shares in the company, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 23,012 shares of company stock valued at $6,386,550 over the last three months. Corporate insiders own 0.60% of the company’s stock.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.